Bristol-Myers Squibb Company (BMY)
Payables turnover
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 15,592,000 | 20,868,000 | 19,649,000 | 19,669,000 | 19,624,000 |
| Payables | US$ in thousands | 3,575,000 | 3,602,000 | 3,259,000 | 3,040,000 | 2,949,000 |
| Payables turnover | 4.36 | 5.79 | 6.03 | 6.47 | 6.65 |
December 31, 2025 calculation
Payables turnover = Cost of revenue ÷ Payables
= $15,592,000K ÷ $3,575,000K
= 4.36
Peer comparison
Dec 31, 2025
Company name
Symbol
Payables turnover
Bristol-Myers Squibb Company
BMY
4.36
AbbVie Inc
ABBV
—
Amgen Inc
AMGN
0.31
Biogen Inc
BIIB
6.71
Eli Lilly and Company
LLY
1.96
Gilead Sciences Inc
GILD
—
Johnson & Johnson
JNJ
2.14
Merck & Company Inc
MRK
—
Organon & Co
OGN
—
Pfizer Inc
PFE
—